Common Medicine Given To Covid 19 Patients In India

Molnupiravir is an orally administered antiviral Covid-19 treatment that currently has emergency use authorization in the United States for use in the high-risk, nonhospitalized population, 26. Some patients who took Paxlovid to treat Covid-19 have experienced cold-like symptoms such as sore throat and cough two weeks after appearing to get better, puzzling physicians and researchers. CDC COVID-19 Response Team et al. (2020) Severe outcomes among patients with coronavirus disease 2019 (COVID-19)—United States 15 February 12–March 16. Morb.

Mortal.